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Introduction
The pathophysiology of meningitis is a complex pro-
cess which consists of factors dependent on the 
micro-organisms (eg. endotoxins, adhesive ability, the 
presence of the areola), and host factors [1, 2]. Proin-
flammatory cytokines, activated by bacterial or viral 
antigens, play a very important role in causing damage 
to the blood-brain barrier, and the result is the penetra-
tion of bacteria into the subarachnoid space and the 
development of the classic symptoms of the disease 
[3, 4]. Various courses of disease from mild to very 
severe in the case of the same causative pathogens 
have been observed, indicating that the proinflamma-
tory pathway and defects in inhibitors of the inflam-
matory pathway play a very important predictive role. 
Single nucleotide polymorphisms (SNPs), genes that 
encode cytokines, influence the severity of the inflam-
matory response. Identifying these will allow an accu-
rate assessment of the patient’s prognosis. Classifi -
cation of meningitis depends on the type of etiologic 
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agent, there are two main groups: bacterial meningi-
tis (BM) and viral meningitis (VM) [5, 6]. BM, due to the 
type of pathogens that cause inflammation are divided 
into purulent and non-purulent [5, 7]. VM are usually 
mild, with a self-limited course and rarely cause neu-
rological sequelae, and have a low mortality rate [6, 8, 
9]. However, there are cases of VM described with quite 
dramatic courses [5,8–10].
Aim
The aim of our study was to evaluate the influence of 
interleukin-1β (IL-1β), tumor necrosis factor (TNF-α) 
and interleukin 8 (IL-8) gene polymorphisms on the 
development and intensity of inflammation markers 
during the course of neurologic infections in patients 
treated in the Department of Infectious and Tropical 
Diseases, University Hospital in Krakow, Poland.
Material and Methods
We evaluated the results of 30 patients, 12 men and 
18 women treated for BM and VM in the Department 
of Infectious and Tropical Diseases at the University 
Hospital in Krakow [mean age: 39.9 years]. The con-
trol group consisted of 30 healthy volunteers, 19 men 
and 11 women [mean age 44.6]. The study included 11 
patients with BM and 19 patients with VM. Exclusion 
criteria included: other acute and chronic inflammato-
ry states of immunosuppression and immunosuppres-
sive therapy. In the test group, we analyzed blood mor-
phology, the concentration of C reactive protein (CRP) 
in the blood, and tested the cerebrospinal fluid (CSF) 
for the number of cells, and concentrations of glucose 
and protein using standard methods. Patients and 
control subjects were evaluated for polymorphisms of 
IL-1β + 3953AG (rs1143634), -31AG (rs 1143627), TNF-α 
-308AG (rs1800629) and IL-8 + 781AG (rs2227306). 
For this purpose, DNA was isolated from blood using 
a DNA Qiamp DNA Mini Kit in accordance with manu-
facturer recommendations (Qiagen, Germany). After 
quantitative and qualitative assessments, the DNA 
samples were normalized to a concentration of 9 ng/ul. 
Genotyping was performed using a TaqMan SNP Geno-
typing Kit (Life Technologies, USA) and CFX384 Touch 
Real Time PCR Detection System (Bio-Rad, USA).
Statistical methods
We used nonparametric tests for statistical analy-
sis. For comparison of the two groups, we used the 
Mann-Whitney test. Interdependence between select-
ed parameters was determined by the Pearson correla-
tion coeffi cient. Effects of polymorphisms on the level 
of the selected parameters were analyzed using ANO-
VA-Kruskal-Wallis. We also used the Chi2 test of inde-
pendence. A P value <0.05 was considered statistically 
signifi cant. Calculations were performed using Statis-
tica 10 (StatSoft® Inc., U.S.).
The study was Conducted in Accordance with the 
Declaration of Helsinki (1975) and approved by the 
Jagiellonian University Ethics Committee. All partici-
pants of the study signed an informed consent form.
Results
In the test and control groups, there was no statisti-
cally signifi cant difference in gender (p = 0.07) or age 
(p = 0.21). The 19 patients with VM had an average CRP 
concentration of 7.40 mg/l (1.00–37.10 mg/l) whereas 
the group of 11 patients with BM the average CRP con-
centration was 74.02 mg/l (34.00–135.62 mg/l); the 
difference between the groups was statistically signifi -
cant (p = 0.005). The WBC count (x10'3 /ml) was 7.83 
(5.43–10.00) in the VM and 16.54 (6.37–22.12) in the 
BM, with a statistically signifi cant (<0.001) difference. 
CSF analysis of the VM group showed 83.00 cells/ml 
(37.00–272.00), 0.72 g/L of protein (0.43–0.83) and 
2.79 mmol/L of glucose (2.49–3.20). The BM group 
had an average of 398 cells/ml (37.00–1150.00), 1.45 
g/L of protein (1.00–2.89), and 1.51 mmol/L of glucose 
(1.10–2.05). Statistically signifi cant differences were 
observed between the two groups in the blood glucose 
(p = 0.001) and protein (p = 0.003).
There was a statistically signifi cant difference in 
the distribution of AA genotype of the IL-1β -31 poly-
morphism (p < 0.001) between the test and control 
groups. The IL-1β -31AA genotype was present in the 
healthy group but not in the test group. In addition, 
the GG polymorphism was more frequently observed 
in the test group than in the control group. In terms of 
the other assessed polymorphisms, IL-1β 3953, TNF-α 
-308, IL-8 781, there was no statistically signifi cant 
difference in the distribution of these polymorphisms 
between the test and control groups (Table 1).
We assessed for the association between the 
examined gene polymorphisms and inflammatory 
parameters of blood and CSF. We observed a relation-
ship between the number of WBC and the TNF-α -308 
polymorphism, wherein a statistically signifi cant dif-
ference existed between the AA and AG (p = 0.02). In 
terms of the other assessed polymorphisms, IL-1β 
3953, TNF-α -308, and IL-8 781, there was no statisti-
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cally signifi cant relationship between them and WBC, 
CRP, TNF-α IL-1β in CSF, or inflammatory parameters 
of CSF: white cells, protein, and glucose.
Discussion
Our study for the fi rst time evaluated the IL-8 + 781 
polymorphism in infection, and polymorphisms of the 
IL-1β: -31 and +3953 in neurological infections. A limi-
tation of our study is that due to the small sample size, 
the selected gene polymorphisms of IL-1β, TNF-α and 
IL-8 were analyzed together in both types of meningitis. 
We have shown that the IL-1β -31AA genotype 
demonstrates a statistically signifi cant (p <0.001) dif-
ference between the test and control groups. Patients 
in the test group did not have the IL-1β -31AA genotype, 
while this genotype was present in the control group. 
It is possible that this genotype protects against the 
development of meningitis. This issue requires fur-
ther research on a larger group of patients. In addition, 
more patients in the test group were found to have the 
GG genotype.
Thus far, the incidence of the IL-1β -31 polymor-
phism in neurologic infections has not been evaluated. 
The effects of IL-1β polymorphisms have been demon-
strated in sepsis. Wen et al. observed that a polymor-
phism at position 1470 GG, AG and 51 31GA increases 
the risk of severe sepsis in patients after trauma [11]. 
Polymorphisms at positions -31 (G/A) and -511 (A/G) 
are also associated with more severe infections of 
Plasmodium falciparum [12]. Liu et al., demonstrat-
ed a correlation between the presence of a G allele at 
position 31, and susceptibility to infection with influ-
enza virus AH1N1pdm09 [13]. Allele 511G, the GG gen-
otype, and haplotype 511G/3953G can be considered 
one of the factors responsible for susceptibility to the 
development of visceral leishmaniasis, as opposed to 
the A allele or AA genotype at position 511 and hap-
lotype 511A/3953, which can be considered as factors 
promoting immunity against the disease [14]. Poly-
morphisms at position 3953 (G/A) was also observed 
in chronic hepatitis caused by HCV genotype 4, where 
the presence of the A allele was associated with poor-
er clinical response and more severe fi brosis [15]. 
Sa-Ngasang et al., showed that carriers of IL1β -31G 
have a higher risk of developing shock during Den-
gue fever (Dengue Shock Syndrome), which suggests 
a connection with production of interleukins in the 
pathogenesis of the disease [16].
The most widely investigated polymorphism of the 
gene encoding TNF-α is a polymorphism in the pro-
moter region at position 308. Depending on the purine 
presence, two TNF-α alleles may be present: guanine 
at position -308 is associated with TNF-α 1 and ade-
nine at this position is associated with TNF-α 2. Allele 
TNF-α 2 is less frequent, and it is associated with high-
er production of TNF-α as compared to TNF-α 1 [17]. 
However, the occurrence of a polymorphism at position 
-863 (G/A) is associated with a lower expression of the 
gene and lower levels of this cytokine [18]. Research on 
Table 1. Genotype frequencies of IL-1β, TNF-α and IL-8 genes in patients with 
meningitis and controls
SNP
Test group Control group Chi2 test
pn GF (%) n GF (%)
IL-1β +3953
GG  20 66.67 18 60
p = 0.56AG  10 33.33 11 36.67
AA 0 0.00  1 3.33
IL-1β -31
GG 18 60.00   3 10.00
p < 0.001AG 12 40.00 16 53.33
AA  0 0.00 11 36.67
TNF-α -308
GG 19 63.33 20 66.67
p = 0.84AG 9 30.00 9 30.00
AA 2 6.67 1 3.33
IL-8 +781 
GG 3 10.00 7 23.33
p = 0.20AG 8 26.67 7 23.33
AA 16 53.33 16 53.33
GF, genotype frequencies; IL-1β, interleukin 1β; IL-8, interleukin 8; SNP, single nucle-
otide polymorphism, TNF-α, tumor necrosis factor α
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the effects of the presence of TNF-α polymorphisms 
on the course neurologic infections are few. Titmarsh 
et al., evaluated the polymorphism of TNF-α -308 
in groups of patients with VM, specifi cally invasive 
meningococcal disease (IMD) compared to a control 
group. They showed signifi cant differences between 
the groups, with the genotype GG of TNF-α -308 poly-
morphism associated with a lower production of TNF-α 
which correlated with a higher risk of developing IMD 
[19]. Pujikhari et al. showed that people with -308 alle-
les and -863G allele were more likely to develop severe 
Japanese encephalitis [20]. Fontes et al., in compar-
ing the distribution of TNF-α -308 genotypes demon-
strated that the TNF-α -308 is present more often in 
BM patients than in healthy people [21].
Polymorphisms in the region of -308 have been 
demonstrated in other acute infections, bacterial, viral, 
or parasitic. Thus far a correlation between the occur-
rence of allele TNF-α 2 and more severe malaria has 
been shown. McGuire et al. observed that children who 
are homozygous for TNF-α 2/2 were at seven times 
greater risk of developing the cerebral form of malaria 
or death [22]. Similarly, Cabrera et al. observed a cor-
relation between the presence of the allele of TNF-α 
2 and susceptibility to mucocutaneous leishmania-
sis infection [23]. With respect to the role of TNF-α in 
the development of septic shock, polymorphisms of 
the gene coding for TNF-α have been demonstrated 
to have an effect on the course of sepsis. Song et al. 
have demonstrated the relationship between the pres-
ence of the TNF-α 2 allele and the risk of severe sepsis, 
but no correlation was observed with the occurrence of 
this polymorphism and death [24]. Teuffel et al., came 
to similar conclusions in their meta-analysis [25]. Pol-
ymorphisms in the region of 308 were also demon-
strated in the course of viral infections. The presence 
of the TNF-α 2 allele, and thus increased production of 
TNF-α, was associated with an increased risk of haem-
orrhagic dengue fever when re-developing the disease 
[26]. In the course of infection with influenza virus 
AH1N1pdm09 the presence of -308G allele was associ-
ated with more severe disease [27].
In terms of the analyzed polymorphisms of TNF-α 
-308 in our study there was no statistically signifi -
cant difference in the distribution between the test and 
control groups. The WBC count was dependent on the 
TNF-α-308 polymorphism, but statistical signifi cance 
was only reached between AA and AG. TNF -308 poly-
morphisms did not affect other analyzed parameters: 
CRP in the peripheral blood and CSF studies: TNF-α, 
IL-1β, cell count, protein, or glucose.
Studies on the effect of SNP IL-8 in the course of 
infection are few, and primarily surround infections 
of the gastrointestinal tract. Jiang et al. demonstrat-
ed in 2 separate studies that the AA genotype at the 
-251 position of the IL-8 is a signifi cant risk factor for 
primary CDI [28, 29]. Jiang et al. further demonstrated 
the influence of the same polymorphism on the devel-
opment of the enteroaggregative forms of Escherichia 
coli (EAEC) [30]. In terms of neurologic infection, Tit-
marsh et al., compared the prevalence of polymor-
phisms of IL-8 -251 in groups of patients with VM, IMD, 
and healthy controls. Signifi cant difference between 
groups was noted; for the IL-8 -251 polymorphism, IL-8 
-251AA was associated with a higher risk of VM [19].
In our study we chose the IL-8 SNP +781, which has 
not been analyzed in the progression of any infection. 
No statistically signifi cant difference in IL-8 +781 pol-
ymorphisms were noted between the test and control 
groups. Polymorphisms of IL-8 +781 had no impact on 
peripheral blood WBC, CRP, TNF-α, IL-1β or CSF stud-
ies, specifi cally: cell count, protein and glucose.
As a conclusion, we observed that the IL-1β -31AA 
genotype may play a protective role in the course of 
neurologic infection – it was not observed in patients 
who presented with this disease. The WBC count in 
peripheral blood correlated with the TNF-α -308 poly-
morphism, and there was a statistically signifi cant dif-
ference between the AA and AG subsets.
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